Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma

In China, the adjuvant epirubicin and docetaxel (ED) regimen is widely used as a substitute for the epirubicin and cyclophosphamide followed by docetaxel (EC-D) regimen in patients with operable breast cancer. However, their equivalence has not yet been demonstrated. This retrospective study compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Liyu, Jing, Chuyu, Kong, Xiaoli, Li, Xiaoyan, Ma, Tingting, Huo, Qiang, Chen, Junfei, Wang, Xiaoting, Yang, Qifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950445/
https://www.ncbi.nlm.nih.gov/pubmed/27446451
http://dx.doi.org/10.3892/ol.2016.4754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950445/
https://www.ncbi.nlm.nih.gov/pubmed/27446451
http://dx.doi.org/10.3892/ol.2016.4754

Ejemplares similares